caffeic acid has been researched along with Lung Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Huang, X; Huang, Y; Jiang, B; Jiang, J; Shen, H; Sun, Y; Wu, X; Xu, J; Xu, S; Yao, H; Zhang, P | 1 |
| An, H; Bai, X; Guo, S; Kang, X; Li, S; Liu, X | 1 |
| Min, J; Shen, H; Wang, Q; Wang, ZN; Xi, W; Yang, Q; Yin, L; Yu, Y; Zhang, Y | 1 |
| Sun, FM; Tsai, CM; Weng, CJ; Yang, SF; Yen, GC | 1 |
| Chang, WC; Chang, WT; Chen, JY; Chen, RF; Chiu, CC; Chou, HL; Chu, YC; Fong, Y; Lin, CL; Wang, HM; Wu, CY | 1 |
| Ou-Yang, ZG; Shao, RG; Song, DQ; Xu, F; Zhang, SH; Zhen, YS | 1 |
6 other study(ies) available for caffeic acid and Lung Neoplasms
| Article | Year |
|---|---|
Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Lipoxygenase Inhibitors; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles | 2016 |
Caffeic Acid, an Active Ingredient in Coffee, Combines with DOX for Multitarget Combination Therapy of Lung Cancer.
Topics: Apoptosis; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Coffee; Doxorubicin; Humans; Lung Neoplasms; Molecular Docking Simulation; Xenograft Model Antitumor Assays | 2022 |
Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 9; Cell Line; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Paclitaxel; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2 | 2018 |
Assessment of the anti-invasion potential and mechanism of select cinnamic acid derivatives on human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Caffeic Acids; Cell Adhesion; Cell Line, Tumor; Chlorogenic Acid; Cinnamates; Coumaric Acids; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Signal Transduction | 2013 |
Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; NF-kappa B; Paclitaxel; Signal Transduction; Survivin; Up-Regulation | 2012 |
Sodium caffeate induces endothelial cell apoptosis and inhibits VEGF expression in cancer cells.
Topics: Apoptosis; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Endothelial Cells; Humans; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Prostatic Neoplasms; Umbilical Veins; Vascular Endothelial Growth Factor A | 2006 |